Loading stock data…
$100.17+0.16 (+0.15%)
Lantheus Holdings, Inc.
Lantheus Holdings, Inc. in the Healthcare sector is trading at $100.17 with a market capitalization of $6.6B. Wall Street consensus targets $106.99 (8 analysts), implying a +6.8% move over the next 12 months. The stock is currently near its 52-week high of $111.86, remaining 12.0% above its 200-day moving average. On fundamentals, Piotroski 3/9 flags weak fundamentals, Altman Z in the safe zone. The Whystock Score of 85/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $388.18M↑ | $377.33M↓ | $406.79M↑ | $384.01M↑ | $378.05M |
| Gross Profit | $241.85M↑ | $230.92M↓ | $240.88M↑ | $222.37M↓ | $241.01M |
| Operating Income | $100.22M↑ | $81.33M↑ | $77.18M↑ | $43.62M↓ | $87.97M |
| Net Income | $75.03M↓ | $118.42M↑ | $54.09M↑ | $27.77M↓ | $78.75M |
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in diagnosis and treatment of heart, cancer, and other diseases worldwide. The company offers DEFINITY, an injectable ultras...